117 related articles for article (PubMed ID: 12117320)
1. Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region.
Watanabe K; Sakamoto M; Somiya M; Amin MR; Kamitani H; Watanabe T
Neurol Res; 2002 Jul; 24(5):485-90. PubMed ID: 12117320
[TBL] [Abstract][Full Text] [Related]
2. Establishment of experimental glioma models at the intrinsic brainstem region of the rats.
Sho A; Kondo S; Kamitani H; Otake M; Watanabe T
Neurol Res; 2007 Jan; 29(1):36-42. PubMed ID: 17427273
[TBL] [Abstract][Full Text] [Related]
3. A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells.
Wasita B; Kamitani H; Kinoshita Y; Mamun MH; Watanabe T
Neurol Res; 2009 Jun; 31(5):453-62. PubMed ID: 19309540
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
[TBL] [Abstract][Full Text] [Related]
5. Growth control of C6 glioma in vivo by nerve growth factor.
Kimura S; Yoshino A; Katayama Y; Watanabe T; Fukushima T
J Neurooncol; 2002 Sep; 59(3):199-205. PubMed ID: 12241115
[TBL] [Abstract][Full Text] [Related]
6. Invading C6 glioma cells maintaining tumorigenicity.
Chicoine MR; Silbergeld DL
J Neurosurg; 1995 Oct; 83(4):665-71. PubMed ID: 7674017
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
[TBL] [Abstract][Full Text] [Related]
8. Reduced tumorigenicity of rat glioma cells in the brain when mediated by hygromycin phosphotransferase.
Hormigo A; Friedlander DR; Brittis PA; Zagzag D; Grumet M
J Neurosurg; 2001 Apr; 94(4):596-604. PubMed ID: 11302658
[TBL] [Abstract][Full Text] [Related]
9. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM
BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949
[TBL] [Abstract][Full Text] [Related]
10. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.
Saleh M; Wiegmans A; Malone Q; Stylli SS; Kaye AH
J Natl Cancer Inst; 1999 Mar; 91(5):438-45. PubMed ID: 10070943
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of a Wistar rat model bearing brain glioma C6 cells and its experimental application].
Yi LH; Fu XP; Li AM; Yan RM
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):277-9. PubMed ID: 21354911
[TBL] [Abstract][Full Text] [Related]
12. Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours.
Whittle IR; Macarthur DC; Malcolm GP; Li M; Washington K; Ironside JW
J Neurooncol; 1998 Feb; 36(3):231-42. PubMed ID: 9524101
[TBL] [Abstract][Full Text] [Related]
13. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.
Parsa AT; Chakrabarti I; Hurley PT; Chi JH; Hall JS; Kaiser MG; Bruce JN
Neurosurgery; 2000 Oct; 47(4):993-9; discussion 999-1000. PubMed ID: 11014444
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models.
Tzerkovsky DA; Osharin VV; Istomin YP; Alexandrova EN; Vozmitel MA
Exp Oncol; 2014 Jun; 36(2):85-9. PubMed ID: 24980761
[TBL] [Abstract][Full Text] [Related]
15. Study of in vitro and in vivo effect of docosahexaenoic acid on rat C6 glioma.
Nasrollahzadeh J; Siassi F; Doosti M; Eshraghian MR
J Exp Ther Oncol; 2009; 8(2):95-103. PubMed ID: 20192116
[TBL] [Abstract][Full Text] [Related]
16. Histological characteristics and markers of proliferation and differentiation in rat brain with experimental glioma.
Ristić S; Mirić M; Jović S; Ristić S; Karić J
Vojnosanit Pregl; 2014 Sep; 71(9):828-32. PubMed ID: 25282780
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
[TBL] [Abstract][Full Text] [Related]
18. Development of a xenograft glioma model in mouse brain.
Kaye AH; Morstyn G; Gardner I; Pyke K
Cancer Res; 1986 Mar; 46(3):1367-73. PubMed ID: 3943101
[TBL] [Abstract][Full Text] [Related]
19. Development of a rat C6 brain tumor model.
Zhang X; Wu J; Gao D; Fei Z; Qu Y; Jing J
Chin Med J (Engl); 2002 Mar; 115(3):455-7. PubMed ID: 11940388
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the antiangiogenic effect of Kringle 1-5 in a rat glioma model.
Lin YL; Tsai MJ; Lo MJ; Chang SE; Shih YH; Lee MJ; Kuo HS; Kuo WC; Huang WC; Cheng H; Huang MC
Neurosurgery; 2012 Feb; 70(2):479-89; discussion 489-90. PubMed ID: 21796002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
